VYM250117P105000
- 0.13
- 0.000.00%
Vanguard High Dividend Yield ETF Newsroom
Wells Fargo's Harvey: Investors Could Be Driving Pricing Strategy in Stocks
Exxon Mobil Shares Are Trading Higher After Truist Securities Raised Its Price Target on the Stock From $117 to $119.
Intra-Cellular Therapies Stock Is Surging Monday: What's Going On?
BofA Sees 'Surprising' Broadening of Rally in Semis to Start 2025
Most and Least Shorted S&P 500 Financial Stocks in December
Supreme Court Allows Climate Lawsuits Against Oil Companies to Proceed
The Top and Bottom Contributors to S&P 500's Q4 EPS Growth
Decoding Home Depot's Options Activity: What's the Big Picture?
James Comer Discloses Buys of Apple, Broadcom, Microsoft, Others
Shares of Oil-related Companies Are Trading Higher Amid New U.S. Sanctions Towards Russia's Energy Supply Chain.
Nasdaq, S&P, and Dow Trade Mixed as Inflation Data and Bank Earnings Loom
Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal
'Walmart GoLocal And IBM Collaboration Makes Last-Mile Delivery Easier For Retailers' - IBM
Exxon Mobil Analyst Ratings
Intra-Cellular surged nearly 35%! Johnson & Johnson plans to spend $10 billion to acquire the company, marking the largest Biotechnology merger in nearly two years!
This is the largest Trade in the biotechnology Industry in nearly two years, and it is also the first Biomedical merger exceeding 10 billion dollars since 2024, indicating a resurgence in merger and acquisition activities in the Medical Care sector. Goldman Sachs stated that the potential financing capacity of large Biopharmaceutical companies is at least 500 billion dollars, providing significant operational space for R&D investment, merger expansion, and more.
Walmart Announces Brand Refresh Embracing Evolution And Legacy To Enhance Customer Experience; Focus On Health, Wealth, And Sustainability
VYM Vs SCHD: Which Dividend ETF Should You Buy in 2025?
Chevron Analyst Ratings
Broadcom Issues $3B Senior Notes, $1.1B At 4.8% Due 2028, $800M At 5.05% Due 2030, $1.1B At 5.2% Due 2032; To Use Proceeds For General Corporate Purposes And Debt Repayment
US stock outlook | Wall Street begins to discuss the possibility of interest rate hikes! The three major index futures collectively weakened; Intra-Cellular surged nearly 35% in pre-market trading! It will be acquired by Johnson & Johnson for billions.
Tesla fell 3% before the market opened, as the largest Retirement Fund in Europe liquidated its shares; the yield on the 10-year US Treasury is aiming for 5%! The Global bond market is in turmoil.